1. Journal searcher
  2. Top 15 journals in Oncology
  3. Oncotarget
Default: Oncotarget

ISSN:

Journal Home

Journal Guideline

Oncotarget Q2 Unclaimed

Impact Journals LLC United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncotarget is a journal indexed in SJR in Oncology with an H index of 192. It has an SJR impact factor of 0,785 and it has a best quartile of Q2. It has an SJR impact factor of 0,785.

Oncotarget focuses its scope in these topics and keywords: cancer, cell, cells, breast, human, tumor, expression, inhibition, protein, lung, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

WOS
Categories: Oncology (Q2)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Oncotarget

0,785

SJR Impact factor

192

H Index

112

Total Docs (Last Year)

533

Total Docs (3 years)

3197

Total Refs

1007

Total Cites (3 years)

449

Citable Docs (3 years)

1.62

Cites/Doc (2 years)

28.54

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

International Journal of Oncology Q2
Cancer Cytopathology Q2
Cancer Causes & Control Q2
BMC Cancer Q2
Current Opinion in Oncology Q2
Compare this journals

Aims and Scope

cancer, cell, cells, breast, human, tumor, expression, inhibition, protein, lung, carcinoma, growth, patients, prostate, stem, cd, kinase, activation, leukemia, prognostic, signaling, squamous, inhibits,

FAQS

What is the impact factor of Oncotarget?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.